|
FDA
Approves First Ever Inhaled Insulin Combination Product for Treatment of
Diabetes.
Product
name: Exubera
Manufactured
by: Pfizer Inc
Mechanism of
action:
Exubera is a
human form of insulin and as such, lowers blood sugar concentrations by
allowing the blood sugar to be taken up by cells as a source of fuel.
Exubera is a powdered form of insulin that is able to be
inhaled into the lungs through the patient's mouth
using a specially designed inhaler.
Indications:
Side
effects:
-
hypoglycaemia
-
cough
-
shortness of
breath
-
sore throat
and
-
dry mouth
Precautions:
Exubera is not
to be used if you smoke or if you recently quit smoking (within the last 6
months). Exubera is not recommended in patients with asthma, bronchitis, or
emphysema. Baseline tests for lung function are recommended before
beginning treatment and are recommended to be repeated every 6 to 12 months
thereafter.
Source:
FDA
Date:
27/01/06
Links:
Pfizer Plans Mid-July Debut for Inhaled Insulin
Pfizer
EXUBERA - INHALED INSULIN FOR TYPE 1 AND TYPE 2 DIABETES
|